ArticleMetabolic brain disease2022
METTL7B contributes to the malignant progression of glioblastoma by inhibiting EGR1 expression.
Li Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleMetabolic brain disease2022
Li Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.